|
|
 |
| |
 |
Permeation Enhancement Technology |
 |
|
| |
The Path
to Improved Drug Benefits - Permeation enhancement with
CPE-215 is our the drug delivery technology of CPEX. It
has been proven to enhance the absorption of drugs through
the nasal mucosa, skin and eye. It can be adapted to products
formulated as creams, ointments, gels, solutions, sprays
or patches. CPE-215 also has maintained a record of safety
as a direct and indirect food additive and fragrance, and
is listed on the FDA’s inactive ingredient list for approved
use in drug applications. We believe that potential key benefits of
the patented drug delivery formulation technology of CPEX using CPE-215
may include the following therapeutic and commercial opportunities
and advantages:
- Improved compliance and convenience to patients
requiring ongoing injection therapies and the potential
for earlier acceptance of prophylactic treatment for
patients reluctant to use injections;
- Application to injectable peptides that could be
administered intranasally with CPE-215;
- Application to therapeutic molecules that are degraded
by passage through the liver or would benefit from intra-nasal
administration to eliminate first-pass metabolism;
- Application to a variety of metabolic, neurological
and other serious medical conditions;
- Opportunities for life-cycle extension strategies
for existing marketed products;
- Opportunities for allowing product differentiation
based on benefits of administration.
|
| |
| The information posted is as of 07/08/2010 and, to our knowledge,
was timely and accurate when posted. We are under no obligation to update or remove outdated information
other than as required by applicable law or regulation. |
|
| |
|
|
|
